Data may be out of date. Our scheduled checks are behind: the last successful check of the sources finished 20 Oct 2026, 21:00 UTC (14 days ago), more than 36 hours ago. Checks normally run twice daily, so figures on this page may be out of date. See the service status.
ShortageSignal

← All medicines

Medicine · bench card

Sodium Valproate

As of 04 Nov 2026 13:35 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.

Latest England noticeMSN/2026/030 Tier 2 · issued 07 Jul 2026 (120 days ago)
Expected backearly January 2027 as stated in the latest recorded noticethe latest of 3 dates stated for this notice's lines (earliest “late August 2026”); 2 of 3 stated windows have passed stated window still aheadwindow end 10 Jan 2027, derived from “early January 2027”
Protocolno Serious Shortage Protocol matched to this name on the NHSBSA register
ScotlandMSAN(2026)10 issued 25 Feb 2026 — NHS Scotland's own notice, matched by name; kept separate from England

Presentations, as stated in the latest recorded notice

Each line is re-expressed from MSN/2026/030 (07 Jul 2026): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.

PresentationStatus, as statedExpected back, as statedStated in
Sodium valproate (Epilim Chronosphere®) 50mg modified-release granules sachets sugar freeaffected product · inferred from phrasingOut of stock, as statedlate August 2026precision: late in the month · window end 31 Aug 2026, derived from “late August 2026”notice of 07 Jul 2026
Sodium valproate (Epilim Chronosphere®) 250mg modified-release granules sachets sugar freeaffected product · inferred from phrasingOut of stock, as statedearly January 2027precision: early in the month · window end 10 Jan 2027, derived from “early January 2027”notice of 07 Jul 2026
Sodium valproate (Epilim Chronosphere®) 500mg modified-release granules sachets sugar freeaffected product · inferred from phrasingOut of stock, as statedend of September 2026precision: a month · window end 30 Sep 2026, derived from “end of September 2026”notice of 07 Jul 2026
Sodium valproate (Epilim Chronosphere®) 100mg modified-release granules sachets sugar freenamed by the source as remaining available · inferred from phrasingStated as available; cannot support an uplift in demand— not stated for this linenotice of 07 Jul 2026
Sodium valproate (Epilim®) 200mg/5ml syrupnamed by the source as remaining available · inferred from phrasingStated as available; cannot support an uplift in demand— not stated for this linenotice of 07 Jul 2026
Alternative sodium valproate productsclass-level statement by the source, not a named product · inferred from phrasingStated as available— not stated for this linenotice of 07 Jul 2026

Protocol in force

No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.

Named in the source as remaining available

  • Sodium valproate (Epilim Chronosphere®) 100mg modified-release granules sachets sugar free — named by the source as remaining available (inferred from phrasing)
  • Sodium valproate (Epilim®) 200mg/5ml syrup — named by the source as remaining available (inferred from phrasing)

Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.

Identifiers — Sodium Valproate

Also known as
Depakin 200mg/ml oral solution · Dyzantil 200mg modified-release tablets · Dyzantil 300mg modified-release tablets · Dyzantil 500mg modified-release tablets · Epilim 100mg crushable tablets · Epilim 200 gastro-resistant tablets · +56 more
BNF chemical
Sodium valproate 0408010W0 — matched on a generic name
Class
Control of epilepsy · Antiepileptic drugs · Central Nervous System
SNOMED codes
100011000001108, 10415411000001101, 10415611000001103, 10649211000001109, 11072611000001100 and 110 more
Suppliers named in the NHSBSA dataset
A A H Pharmaceuticals Ltd · Actavis UK Ltd · Alliance Healthcare (Distribution) Ltd · Arrow Generics Ltd · Aspire Pharma Ltd · Beacon Pharmaceuticals Ltd · +14 more (from the dataset, not from the notices)
Also recorded under
Epilim (brand) — same BNF chemical; separate pages, separate counts

BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.

BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.

History

Notified short 2 times on record since 2026. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.

Also recorded under

Bracketed names seen in this medicine's notice titles: epilim chronosphere. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.

Scotland — separate record

NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.

Last checked
20 Oct 2026 — sources are checked twice daily by scheduled jobs, not continuously
Last source change
19 Oct 2026
Latest notice captured
10 Jul 2026
Sources
Latest notice post ↗https://cpe.org.uk/our-news/medicine-supply-notification-sodium-valproate-epilim-chronosphere-50mg-250mg-and-500mg-modified-release-granules-sachets-sugar-free/ · methodology · corrections log

Re-expressed facts with links to the source documents; roles are inferred from phrasing and flagged; fuzzy dates stay fuzzy. Not an official NHS or DHSC service and not clinical advice — in a shortage, follow the guidance issued to your pharmacy or prescriber. Absence of a record is never availability.